MedPath
NMPA Approval

Methylphenidate Hydrochloride Prolonged-Release Tablets

国药准字HJ20170265

June 9, 2022

H20170265

Drug Information

盐酸哌甲酯缓释片

专注达

片剂

36mg

化学药品

June 9, 2022

June 8, 2027

Company Information

Applicant Company

1125 Trenton-Harbourton Road, Titusville, NJ 08560 United States of America

Manufacturing Company

State Road 933, KM 0.1, Mamey Ward, Gurabo, PUERTO RICO 00778, United States (USA)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸哌甲酯缓释片 - NMPA 批准文号 | MedPath